Sana Biotechnology (SANA) News Today $1.74 +0.04 (+2.05%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$1.74 -0.01 (-0.57%) As of 05/16/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Sana Biotechnology Up Today?Sana Biotechnology, Inc. (NASDAQ:SANA) shares are under pressure today amid a wave of class-action filings and heightened regulatory scrutiny, although an institutional stake build-up offers some counterbalance. Institutional Buying: Dimensional Fund Advisors LP boosted its position by 44.4% in Q4, acquiring an additional 478,596 shares to hold roughly 1.56 million SANA shares, signaling confidence from a major asset manager. Class-Action Surge: Over the past two days, at least half a dozen law firms—including Levi & Korsinsky, Pomerantz LLP, Bronstein, Gewirtz & Grossman, The Gross Law Firm and Rosen, National Investor Counsel—have announced or reminded investors of pending securities-fraud lawsuits against Sana and certain officers, with a critical May 20, 2025 lead-plaintiff deadline. Investor Alert Coverage: Multiple press releases and newswire alerts (Accesswire, GlobeNewswire, PR Newswire) emphasize potential recoveries for shareholders who incurred losses during the alleged class period (March 17, 2023 to November 4, 2024), adding legal overhang to the stock. Analyst Commentary: An AAII article highlighted that SANA shares fell roughly 5.6%, attributing the drop primarily to the mounting litigation risks and attendant uncertainty around corporate disclosures. In sum, SANA is trading lower as investors weigh the impact of new and expanding securities-fraud lawsuits against the reassurance of fresh buying by Dimensional Fund Advisors.Posted 1+ days agoAI generated SANA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. ...May 17 at 6:20 PM | gurufocus.comSANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsMay 17 at 5:00 PM | businesswire.comSANA Deadline: SANA Investors with Losses in Excess of $100K Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMay 17 at 9:48 AM | prnewswire.comDimensional Fund Advisors LP Buys 478,596 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Dimensional Fund Advisors LP increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 44.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,557,496 shares of the company's stock afterMay 17 at 3:18 AM | marketbeat.comSana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 – SANAMay 16 at 1:12 PM | globenewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANAMay 16 at 5:45 AM | prnewswire.comMay 20, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SANAMay 15 at 1:55 PM | globenewswire.comInvestors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your Rights - SANAMay 15 at 5:45 AM | prnewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana BiotechnologyMay 14, 2025 | globenewswire.comIntegral Health Asset Management LLC Boosts Stake in Sana Biotechnology, Inc. (NASDAQ:SANA)Integral Health Asset Management LLC raised its holdings in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 11.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,000,000 sMay 14, 2025 | marketbeat.comSANA DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important May 20 Deadline in Securities Class Action - SANAMay 13, 2025 | markets.businessinsider.comMay 20, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SANAMay 13, 2025 | globenewswire.comClass Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors - Contact Levi & KorsinskyMay 13, 2025 | prnewswire.comSana Biotechnology (NASDAQ:SANA) Posts Earnings Results, Beats Expectations By $0.02 EPSSana Biotechnology (NASDAQ:SANA - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.02.May 12, 2025 | marketbeat.comSana Biotechnology to Present at the BofA Securities 2025 Healthcare ConferenceMay 12, 2025 | globenewswire.comSana Biotechnology, Inc. Class Action: The Gross Law Firm Reminds Sana Biotechnology, Inc. ...May 12, 2025 | gurufocus.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMay 12, 2025 | gurufocus.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMay 12, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANAMay 12, 2025 | prnewswire.comSana Biotechnology, Inc. Class Action: The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 – SANAMay 12, 2025 | globenewswire.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. ...May 12, 2025 | gurufocus.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law FirmMay 12, 2025 | prnewswire.comSana Biotechnology, Inc. Sued for Securities Law Violations - Investors Should Contact The ...May 12, 2025 | gurufocus.comSana Biotechnology, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your Rights - SANAMay 12, 2025 | prnewswire.comFaruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANAMay 11, 2025 | globenewswire.comSANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMay 9, 2025 | globenewswire.comSana Biotechnology (SANA) Expected to Announce Earnings on WednesdaySana Biotechnology (NASDAQ:SANA) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-sana-biotechnology-inc-stock/)May 9, 2025 | marketbeat.comCompass Rose Asset Management LP Increases Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)Compass Rose Asset Management LP raised its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 150.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 250,000 shares of the company's stock after buying an additional 150,000May 9, 2025 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Crestline Management LPCrestline Management LP decreased its position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 7.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,860,937 shares of the company's stoMay 9, 2025 | marketbeat.comLevi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming DeadlineMay 9, 2025 | prnewswire.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Marshall Wace LLPMarshall Wace LLP reduced its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 94.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 21,322 shares of the company's stock after selling 372,359 shares during thMay 9, 2025 | marketbeat.comSANA LAWSUIT ALERT: Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMay 8, 2025 | globenewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANAMay 8, 2025 | prnewswire.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMay 7, 2025 | prnewswire.comLost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyMay 7, 2025 | markets.businessinsider.comSana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – SANAMay 7, 2025 | globenewswire.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law FirmMay 7, 2025 | prnewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana BiotechnologyMay 7, 2025 | prnewswire.comPrice T Rowe Associates Inc. MD Buys 219,498 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Price T Rowe Associates Inc. MD boosted its stake in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 7.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,108,617 shares of the company's stock after acquMay 7, 2025 | marketbeat.comShareholders that lost money on Sana Biotechnology, Inc. ...May 6, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANAMay 6, 2025 | prnewswire.comShareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact Levi & Korsinsky about pending Class Action - SANAMay 6, 2025 | prnewswire.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC grew its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 1,838.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 319,818 shares of the company's stock afteMay 6, 2025 | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit – SANAMay 5, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANAMay 5, 2025 | globenewswire.comShareholders that lost money on Sana Biotechnology, Inc. ...May 5, 2025 | gurufocus.comShareholders that lost money on Sana Biotechnology, Inc.(SANA) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreMay 5, 2025 | prnewswire.comSana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Moderate Buy" by BrokeragesSana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommMay 5, 2025 | marketbeat.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMay 5, 2025 | gurufocus.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMay 5, 2025 | prnewswire.com Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address SANA Media Mentions By Week SANA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SANA News Sentiment▼0.110.60▲Average Medical News Sentiment SANA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SANA Articles This Week▼256▲SANA Articles Average Week Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APGE News Today SDGR News Today CNTA News Today BHC News Today ARQT News Today AGIO News Today GLPG News Today IRON News Today IDYA News Today INDV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SANA) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Two drop-dead simple ways to play the gold boomIf you take a few minutes to check out the short research briefing Mark & I have put together, I’m confident y...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SANA Stock Free SANA Stock Alerts